III John Osborne Lilly
III John Osborne Lilly's purchase track record
III John Osborne Lilly has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/1/2025 | FIG | $2.06M | -59.2% | -78.8% | +11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Duolingo Sets Q3 2026 Earnings Release, Stock Climbs. Duolingo announced it will report its third‑quarter 2026 results on Tuesday, November 3. The shares rose even as the broader market slipped, and the company has recently outperformed market returns. Analysts at Baillie Gifford noted a rebound in Duolingo’s stock, adding to the positive sentiment.
Transaction History
| FIG | ▼ Sell | Other | 330,306 | $0 | 8/28/2026 | View on chart |
| FIG | ▼ Sell | Other | 5,460 | $0 | 8/28/2026 | View on chart |
| FIG | ▼ Sell | Other | 406,168 | $0 | 8/7/2026 | View on chart |
| FIG | ▼ Sell | Other | 6,825 | $0 | 8/7/2026 | View on chart |
| DUOL | ▲ Buy | Grant | 118 | $15K | 7/10/2026 | View on chart |
| DUOL | ▲ Buy | Grant | 2,001 | $0 | 6/3/2026 | View on chart |
| FIG | ▲ Buy | Grant | 12,415 | $0 | 6/2/2026 | View on chart |
| FIG | ▼ Sell | Other | 422 | $0 | 11/13/2025 | View on chart |
| FIG | ▲ Buy | Open Market | 62,500 | $2.1M | 8/1/2025 | View on chart |
| DUOL | ▲ Buy | Grant | 379 | $0 | 6/11/2025 | View on chart |
| DUOL | ▲ Buy | Grant | 895 | $0 | 6/12/2024 | View on chart |
| DUOL | ▲ Buy | Grant | 1,016 | $0 | 6/15/2023 | View on chart |
| DUOL | ▲ Buy | Grant | 1,664 | $0 | 6/9/2022 | View on chart |
| DUOL | ▲ Buy | Grant | 2,950 | $0 | 12/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Figma Analysts See 25% Upside; Revenue Growth Compared to CrowdStrike
Analysts project a 25% upside for Figma, citing strong product adoption. The company’s revenue growth is being compared to CrowdStrike, highlighting its high‑growth trajectory. Figma is also one of the 32 stocks that both Donald Trump and Cathie Wood have bet on.
Figma Analysts See 25% Upside; Revenue Growth Compared to CrowdStrike. Analysts project a 25% upside for Figma, citing strong product adoption. The company’s revenue growth is being compared to CrowdStrike, highlighting its high‑growth trajectory. Figma is also one of the 32 stocks that both Donald Trump and Cathie Wood have bet on.